Price$371.43-13.00 (-3.38%)
01:30 PM07:45 PM
News · 26 weeks66+150%
2026-01-182026-07-12
Mix2690d
- Insider9(35%)
- SEC Filings8(31%)
- Other4(15%)
- Earnings3(12%)
- Offering1(4%)
- Analyst1(4%)
Latest news
25 items- SECHCA Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - HCA Healthcare, Inc. (0000860730) (Filer)
- PRHCA Healthcare, Inc. 2nd Quarter 2026 Earnings Conference CallHCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 2Q 2026 Earnings Call When: Friday, July 24, 2026, at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, frank.morgan@hcahealthcare.com If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/news/home/20260714544676/en/ INVESTOR CONTACT: Frank Morg
- PRHCA Healthcare Previews Second Quarter 2026 ResultsRevises 2026 Guidance HCA Healthcare, Inc. (NYSE:HCA) today announced preliminary financial and operating results for the second quarter ended June 30, 2026. The preliminary financial and operating results are subject to finalization of the Company's quarterly financial and accounting procedures. HCA anticipates revenues in the second quarter of 2026 to approximate $20.230 billion, compared to $18.605 billion in the second quarter of 2025. Net income attributable to HCA Healthcare, Inc. is expected to approximate $1.699 billion, or $7.62 per diluted share, compared to $1.653 billion, or $6.83 per diluted share, in the second quarter of 2025. Results for the second quarter of 2026 includ
- ANALYSTHCA downgraded by Barclays with a new price targetBarclays downgraded HCA from Overweight to Equal Weight and set a new price target of $427.00
- PRHCA Healthcare Announces New England Journal of Medicine Study Highlighting Advances in CRISPR-based Therapy for ChildrenFirst published data evaluating gene-editing treatment in children ages 5-11 with inherited blood disorders highlights the potential for earlier intervention before cumulative injury HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced new research published in The New England Journal of Medicine (NEJM) demonstrating promising results from a gene-editing therapy being investigated in children ages 5-11 with severe sickle cell disease and transfusion-dependent beta thalassemia. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260629348492/en/The current NEJM study builds on HCA Health
- SECSEC Form 8-K filed by HCA Healthcare Inc.8-K - HCA Healthcare, Inc. (0000860730) (Filer)
- PRHCA Healthcare Announces Agreement to Acquire The College of Health Care ProfessionsHCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, and The College of Health Care Professions (CHCP), one of the largest allied healthcare training providers in Texas, today announced an agreement for HCA Healthcare to acquire ownership of CHCP. CHCP provides healthcare education to more than 8,000 students annually across 10 campuses throughout Texas and online. "The College of Health Care Professions has built a strong legacy of preparing skilled and compassionate healthcare professionals," said Sam Hazen, CEO of HCA Healthcare. "Together, we are investing in the future of healthcare and strengthening the talent pipeline that will serve patients and commu
- INSIDEREVP and CFO Marks Mike A gifted 3,336 shares and received a gift of 3,336 shares, closing all direct ownership in the company (SEC Form 4)4 - HCA Healthcare, Inc. (0000860730) (Issuer)
- INSIDERDirector Frist William R was granted 809 shares, increasing direct ownership by 6% to 13,740 units (SEC Form 4)4 - HCA Healthcare, Inc. (0000860730) (Issuer)
- INSIDERDirector Frist Thomas F Iii was granted 1,041 shares, increasing direct ownership by 7% to 15,858 units (SEC Form 4)4 - HCA Healthcare, Inc. (0000860730) (Issuer)
- INSIDERDirector Smith Andrea B was granted 509 shares, increasing direct ownership by 12% to 4,666 units (SEC Form 4)4 - HCA Healthcare, Inc. (0000860730) (Issuer)
- INSIDERDirector Riley Wayne Joseph was granted 509 shares, increasing direct ownership by 4% to 15,029 units (SEC Form 4)4 - HCA Healthcare, Inc. (0000860730) (Issuer)
- INSIDERDirector Michelson Michael W was granted 925 shares, increasing direct ownership by 8% to 12,576 units (SEC Form 4)4 - HCA Healthcare, Inc. (0000860730) (Issuer)
- INSIDERDirector Johnston Hugh F was granted 809 shares, increasing direct ownership by 22% to 4,475 units (SEC Form 4)4 - HCA Healthcare, Inc. (0000860730) (Issuer)
- INSIDERDirector Deparle Nancy Ann was granted 509 shares, increasing direct ownership by 2% to 21,910 units (SEC Form 4)4 - HCA Healthcare, Inc. (0000860730) (Issuer)
- INSIDERDirector Chidsey John was granted 809 shares, increasing direct ownership by 163% to 1,305 units (SEC Form 4)4 - HCA Healthcare, Inc. (0000860730) (Issuer)
- PRHCA Healthcare, Inc. to Present at May ConferenceHCA Healthcare, Inc. (NYSE:HCA) is scheduled to present at the following healthcare conference: May 20, 2026, at 11:30am ET at the RBC Global Healthcare Conference A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relations section of the Company's website, www.hcahealthcare.com. Dates and times may be subject to change, please check the conference schedule or the Investor Relations section of the Company's website for the latest information. About HCA Healthcare Nashville-based HCA Healthcare is one of the nation's leading providers of healthcare services comprising 189 hospitals and approxi
- SECHCA Healthcare Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits8-K - HCA Healthcare, Inc. (0000860730) (Filer)
- SECSEC Form 10-Q filed by HCA Healthcare Inc.10-Q - HCA Healthcare, Inc. (0000860730) (Filer)
- SECSEC Form 8-K filed by HCA Healthcare Inc.8-K - HCA Healthcare, Inc. (0000860730) (Filer)
- SECSEC Form FWP filed by HCA Healthcare Inc.FWP - HCA Healthcare, Inc. (0000860730) (Subject)
- PRHCA Healthcare Names Cynthia Cifuentes-Finkel Senior Vice President of Marketing and Corporate AffairsHCA Healthcare (NYSE:HCA) today announced that Cynthia Cifuentes-Finkel has been named senior vice president of marketing and corporate affairs, effective June 8, 2026. She will report to Mike McAlevey, executive vice president, chief legal and administrative officer, and will lead enterprise marketing, corporate communications, and stakeholder engagement in support of HCA Healthcare's enterprise growth priorities. "Cynthia is a strategic and accomplished leader with deep experience building trusted brands, strengthening reputation and aligning communications with organizational strategic imperatives," said McAlevey. "She brings a strong track record of leading high-performing teams, navi
- SECHCA Healthcare Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - HCA Healthcare, Inc. (0000860730) (Filer)
- PRHCA Announces Proposed Public Offering of Senior NotesHCA Healthcare, Inc. (NYSE:HCA) today announced that its wholly owned subsidiary, HCA Inc., proposes to offer senior notes, subject to market and other considerations. Actual terms of the senior notes, including maturity, interest rate and principal amount, will depend on market conditions at the time of pricing. HCA Inc. intends to use the net proceeds from this offering for general corporate purposes, which may include the repayment of outstanding borrowings under its $4.000 billion commercial paper program (which may be reborrowed from time to time), and may use a portion of the net proceeds from this offering for the redemption of all or a portion of the $1.500 billion outstanding aggre
- SECHCA Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits8-K - HCA Healthcare, Inc. (0000860730) (Filer)
HCA FAQ
8 questionsWhat does HCA Healthcare Inc. do?
HCA Healthcare, Inc., through its subsidiaries, operates as a health care services company in the United States. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, and adolescent and adult alcohol and...Where does HCA stock trade?
HCA Healthcare Inc. (HCA) is listed on NYSE.What sector and industry is HCA in?
HCA Healthcare Inc. operates in the Health Care sector, Hospital/Nursing Management industry.When did HCA Healthcare Inc. go public?
HCA Healthcare Inc. (HCA) completed its IPO in 2011.Does HCA pay a dividend?
HCA's most recent ex-dividend date was 2026-06-16 with a cash dividend of $0.78 per share. No future ex-date is on file yet.What are analysts saying about HCA?
HCA Healthcare Inc. has had 8 recent analyst actions on file. The most recent action was from Barclays: Equal Weight on 2026-07-08.What companies are similar to HCA?
Notable peers in the same industry include THC (Tenet Healthcare Corporation), EHC (Encompass Health Corporation), ENSG (The Ensign Group Inc.), UHS (Universal Health Services Inc.), PACS (PACS Group Inc.). Compare HCA side-by-side with any of them on Quantisnow.How can I track HCA on Quantisnow?
Quantisnow aggregates HCA Healthcare Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow HCA to receive live email and push alerts on every new disclosure.